The Pharmacology Center

Filter Your Results

 

News

 

Amarin’s Vascepa Approved to Reduce Cardiovascular Risk

December 13, 2019 -- Amarin Corporation plc announced that the FDA has approved a new indication and label expansion for Vascepa, the company’s icosapent ethyl capsules.…

Medicure Completes Enrollment in FABOLUS-FASTER Trial of Aggrastat in Patients Undergoing PCI

December 12, 2019 -- Medicure Inc. announced the completion of the FABOLUS-FASTER phase 4 trial of Aggrastat (tirofiban hydrochloride) injection versus Kengreal (cangrelor; Th…

FDA Approves Enoxaparin Sodium Injection in the United States

December 5, 2019 -- Meitheal Pharmaceuticals, a generic injectable pharmaceuticals company based in Chicago, Illinois, announced that the FDA has approved the company's&nb…

ISCHEMIA Provides Clarity on Invasive Strategies Versus Medical Therapy to Manage Higher-Risk Patients With Stable Ischemic Heart Disease

November 16, 2019 -- At the American Heart Association (AHA) scientific sessions 2019, held November 16 -- 18 in Philadelphia, Pennsylvania, Judith S. Hochman, MD, presented f…

New FOURIER Analysis Evaluates Benefit of Repatha for Recent MI

November 19, 2019 -- Amgen announced a new analysis from the FOURIER study, demonstrating a benefit of Repatha (evolocumab) in patients who experienced a recent myocardial inf…

FDA Approves AstraZeneca’s Farxiga for Patients With Type 2 Diabetes

October 21, 2019 -- AstraZeneca announced that the FDA has approved Farxiga (dapagliflozin) to reduce the risk of hospitalization for heart failure in adults with type 2 diabe…

Ticagrelor Monotherapy Shows Promise for Patients Undergoing Multivessel PCI in GLOBAL LEADERS Study

October 17, 2019 -- Data from the GLOBAL LEADERS study suggest that long-term ticagrelor monotherapy after 1-month dual antiplatelet therapy (DAPT) can favorably balance ische…

NICE Publishes Guidance on Rivaroxaban for Preventing Atherothrombotic Events in Patients With CAD or PAD

October 17, 2019 -- The United Kingdom’s National Institute for Health and Care Excellence (NICE) has published its technology appraisal guidance (TA607) on evidence-bas…

 

advertisement

US Device Guide

The Cardiac Interventions Today Europe Device Guide offers a searchable, comprehensive listing of the available interventional cardiology devices in the United States.

 
 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Cardiac Interventions Today

Cardiac Interventions Today (ISSN 2572-5955 print and ISSN 2572-5963 online) is a publication dedicated to providing comprehensive coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions. Cardiac Interventions Today premiered in March 2007 and each edition contains a variety of topics in a flexible format, including articles covering various perspectives on current clinical topics, in-depth interviews with expert physicians, overviews of available technologies, industry news, and insights into the issues affecting today's interventional cardiology practices.